Información del artículo
El Texto completo está disponible en PDF
References
[1.]
J. Keane, S. Gershon, R.P. Wise, E. Mirabile-Levens, J. Kasznica, W.D. Schwieterman, et al.
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.
N Engl J Med, 345 (2001), pp. 1098-1104
[2.]
E.G. Favalli, F. Desiati, F. Atzeni, P. Sarzi-Puttini, R. Caporali, F.B. Pallavicini, et al.
Serious infections during anti-TNFa treatment in rheumatoid arthritis patients.
Autoimmunity Rev, 8 (2009), pp. 266-273
[3.]
R. Day.
Adverse reactions to TNF-alpha inhibitors in rheumatoid arthritis.
Lancet, 359 (2002), pp. 540-541
[4.]
U.R. Hengge, T. Ruzicka, S.K. Tyring, M. Stuschke, M. Roggendorf, R.A. Schwartz, et al.
Update on Kaposi's sarcoma and other HHV8 associated diseases, parts I and II.
Lancet Infect Dis, 2 (2002), pp. 281-292
[5.]
B. González-Sixto, A. Conde, E. Mayo, R. Pardavila, C. De la Torre, M. Cruces.
Sarcoma de Kaposi asociado a corticoterapia sistémica.
Actas Dermosifiliogr, 98 (2007), pp. 553-555
[6.]
E. Antón.
Kaposi's sarcoma in an immunocompetent patient following corticosteroid therapy.
Eur J Intern Med, 19 (2008), pp. 226
[7.]
P.L. Rady, E. Hodak, A. Yen, O. Memar, A. Trattner, M. Feinmesser, et al.
Detection of human herpesvirus-8 DNA in Kaposi's sarcomas from iatrogenically immunosuppressed patients.
J Am Acad Dermatol, 38 (1998), pp. 429-437
[8.]
C.D. Cohen, S. Horster, C.A. Sander, J.R. Bogner.
Kaposi's sarcoma associated with tumour necrosis factor alpha neutralising therapy.
Ann Rheum Dis, 62 (2003), pp. 684
[9.]
M.P. Sánchez-Salas, R. Oncins Torres, I. López Franco.
Sarcoma de Kaposi iatrogénico en una paciente en tratamiento con fármaco anti-TNFa.
Poster presented at the 37th National Conference of the Spanish Academy of Dermatology and Venereology,
Copyright © 2010. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
